Trial Summary
What is the purpose of this trial?
The purpose of this study is to assess the accuracy of ultrasound and traditional fluoroscopy to find the residual fragments before retrograde intrarenal surgery is complete. This would ultimately limit the need for radiation exposure and improve the quality of clinical care given to patients and healthcare teams.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Ultrasound for Kidney Stones Detection is an effective treatment?
The available research shows that ultrasound is effective in detecting kidney stones. One study found that ultrasound correctly identified kidney stones in 96.3% of cases, with no false positives, meaning it was very accurate. Another study compared ultrasound to CT scans and found it to be a reliable method for detecting stones. These findings suggest that ultrasound is a good option for identifying kidney stones, especially since it is noninvasive and does not use radiation like CT scans.12345
What safety data exists for using ultrasound to detect kidney stones?
The provided research does not directly address safety data for ultrasound in detecting kidney stones. However, ultrasound is a widely used diagnostic tool known for its non-invasive nature and lack of ionizing radiation, suggesting a favorable safety profile. The studies focus on the effectiveness and accuracy of ultrasound in detecting and sizing kidney stones, rather than safety concerns.678910
Is Ultrasound a promising treatment for detecting kidney stones?
Yes, ultrasound is a promising treatment for detecting kidney stones. It is non-invasive and can help locate stones accurately, especially larger ones. It is useful in distinguishing stones from tumors and can guide surgeons during operations. Although it may miss some very small stones, it successfully detects most kidney stones.511121314
Research Team
Thomas Chi, M.D.
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for adults over 18 with diagnosed renal or ureteral stones scheduled for retrograde intrarenal surgery (RIRS). It's not suitable for patients having bilateral stone removal, those who refuse consent, pregnant women, kidney transplant recipients, individuals with ectopic kidneys, or if pain can't be managed in the ER.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Ultrasound (Diagnostic Test)
Ultrasound is already approved in Canada for the following indications:
- Kidney stones
- Ureteral stones
- Renal tract disease
- Biliary disease
- Abdominal aortic aneurysm
- Cardiac conditions
- Pregnancy-related conditions
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Suresh Gunasekaran
University of California, San Francisco
Chief Executive Officer since 2022
MBA from Southern Methodist University
Dr. Lukejohn Day
University of California, San Francisco
Chief Medical Officer
MD from Stanford University School of Medicine